SynthesisObesity surgery2025
Metabolic Bariatric Surgery Is Superior to Non-surgical Intervention for the Long-Term Management of Obesity-Related Primary Hypertension: A Systematic Review and Meta-analysis of Randomised Controlled Trials.
Synthesis in Obesity surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- Early Physiologic Derangements for Detection of Major Complications After Bariatric Surgery: A Multicenter Cohort Study.Obesity surgery · 2026Article
- Obesity pillars roundtable: Better together - combined obesity medicine and metabolic surgery care for the treatment of obesity.Obesity pillars · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metabolic bariatric surgery (MBS) may be considered for patients with obesity class III or obesity class II with associated medical problems, including hypertension. However, referrals to MBS teams from hypertension clinics remain low. This meta-analysis of randomised controlled trials compares surgical and non-surgical interventions for the long-term management of obesity-related hypertension. Ten randomised controlled trials were identified, totalling 692 patients. Significant differences were found favouring MBS for all outcomes assessed, including systolic blood pressure (BP) (P < 0.00001), diastolic BP (P = 0.005), changes in systolic (P < 0.0001), and diastolic BP (P = 0.004), number of anti-hypertensives (P = 0.01), mean change in anti-hypertensive use per patient (P = 0.0001), and the number of patients not requiring anti-hypertensives (P = 0.02). MBS significantly improves long-term obesity-related primary hypertension management when compared with non-surgical management. The authors recommend that hypertension guidelines should reflect this.
Indexed as
Identifiers
40670893What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.